Biostage, Inc.

BSTG · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$7,732-$8,945-$6,073-$7,978
Dep. & Amort.$167$134$52$107
Deferred Tax$0$0$0$0
Stock-Based Comp.$2,402$0$1,031$980
Change in WC$0$0-$114$4,686
Other Non-Cash$311$0-$2-$423
Operating Cash Flow-$4,852-$6,939-$5,106-$2,628
Investing Activities
PP&E Inv.$0-$11-$5$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$2,523$0$0
Inv. Sales/Matur.$0$2,523$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$11-$5$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$6,482$5,992$5,060$2,844
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$6,912$6,141$5,060$2,844
Financing Cash Flow$6,912$6,141$5,060$2,844
Forex Effect-$6$0$0$0
Net Chg. in Cash$2,054-$809-$51$216
Supplemental Information
Beg. Cash$432$1,241$1,292$1,076
End Cash$2,486$432$1,241$1,292
Free Cash Flow-$4,852-$6,950-$5,111-$2,628